ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Sotio Acquires Rights to BOXR Cell Therapy Platform contractpharma
September 01, 2020Sotio, a clinical stage immuno-oncology company owned by PPF Group, has acquired the rights to Unum Therapeutics’ BOXR cell therapy platform and BOXR lead programs to develop novel T cell therapies for the treatment of solid tumors.
Pharma Sources Insight January 2025
